Avadel Pharmaceuticals (AVDL) Change in Cash: 2009-2024
Historic Change in Cash for Avadel Pharmaceuticals (AVDL) over the last 16 years, with Dec 2024 value amounting to $20.2 million.
- Avadel Pharmaceuticals' Change in Cash rose 277.80% to $13.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $23.3 million, marking a year-over-year increase of 210.75%. This contributed to the annual value of $20.2 million for FY2024, which is 147.19% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Change in Cash of $20.2 million as of FY2024, which was up 147.19% from -$42.8 million recorded in FY2023.
- In the past 5 years, Avadel Pharmaceuticals' Change in Cash ranged from a high of $61.9 million in FY2020 and a low of -$42.8 million during FY2023.
- Its 3-year average for Change in Cash is $221,000, with a median of $20.2 million in 2024.
- In the last 5 years, Avadel Pharmaceuticals' Change in Cash spiked by 13,696.88% in 2020 and then plummeted by 283.96% in 2023.
- Avadel Pharmaceuticals' Change in Cash (Yearly) stood at $61.9 million in 2020, then plummeted by 133.92% to -$21.0 million in 2021, then skyrocketed by 210.75% to $23.3 million in 2022, then plummeted by 283.96% to -$42.8 million in 2023, then surged by 147.19% to $20.2 million in 2024.